` Comparison: NVCN, ABT - Alpha Spread

NVCN
vs
ABT

Over the past 12 months, NVCN has underperformed ABT, delivering a return of 0% compared to the ABT's +18% growth.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
NVCN
ABT
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

NVCN Intrinsic Value
Not Available
ABT Intrinsic Value
111.69 USD
Overvaluation 16%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Neovasc Inc
TSX:NVCN
40.15 CAD
Abbott Laboratories
NYSE:ABT
132.37 USD
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
NVCN, ABT

NVCN
ABT
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Neovasc Inc
Revenue
Abbott Laboratories
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
NVCN, ABT

NVCN
ABT
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Neovasc Inc
TSX:NVCN
Abbott Laboratories
NYSE:ABT
What is Free Cash Flow?

Gross Margin

NVCN
79.7%
ABT
56.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Neovasc Inc
Abbott Laboratories

Operating Margin

NVCN
-871.8%
ABT
17.9%
LTM 3Y Avg 5Y Avg 10Y Avg
Neovasc Inc
Abbott Laboratories

Net Margin

NVCN
-1 082.9%
ABT
32.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Neovasc Inc
Abbott Laboratories

FCF Margin

NVCN
-656.6%
ABT
15.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Neovasc Inc
Abbott Laboratories

ROE

NVCN
-121.1%
ABT
31.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Neovasc Inc
Abbott Laboratories

ROA

NVCN
-75.4%
ABT
18.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Neovasc Inc
Abbott Laboratories

ROIC

NVCN
-234.5%
ABT
20.6%
LTM 3Y Avg 5Y Avg 10Y Avg
Neovasc Inc
Abbott Laboratories

ROCE

NVCN
-70.4%
ABT
12.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Neovasc Inc
Abbott Laboratories

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
NVCN, ABT

Loading

Performance Gap
NVCN, ABT

Loading
NVCN
ABT
Difference
www.alphaspread.com

Performance By Year
NVCN, ABT

Loading
NVCN
ABT
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare NVCN to other stocks
Unlock Full Access to Alpha Spread
Create Free Account